Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of DOCK4 protein | affects expression | 20106945
|
D017638 |
Asbestos, Crocidolite |
Asbestos, Crocidolite results in increased expression of DOCK4 mRNA | increases expression | 18687144
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of DOCK4 mRNA | decreases expression | 20106945 20064835
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of DOCK4 mRNA | decreases expression | 19150397
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in increased expression of DOCK4 mRNA | increases expression | 15336504
|
D004041 |
Dietary Fats |
Dietary Fats results in increased expression of DOCK4 mRNA | increases expression | 18042831
|
D002117 |
Calcitriol |
Calcitriol results in increased expression of DOCK4 mRNA | increases expression | 16002434
|
D004317 |
Doxorubicin |
DOCK4 protein affects the susceptibility to Doxorubicin | affects response to substance | 16217747
|
C011890 |
kojic acid |
kojic acid results in increased expression of DOCK4 mRNA | increases expression | 16595896
|
C041786 |
palm oil |
palm oil results in increased expression of DOCK4 mRNA | increases expression | 18042831
|
D010634 |
Phenobarbital |
Phenobarbital results in increased expression of DOCK4 mRNA | increases expression | 19270015
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of DOCK4 mRNA | affects binding|increases activity|increases expression | 19710929
|
D018038 |
Sodium Selenite |
Sodium Selenite results in decreased expression of DOCK4 mRNA | decreases expression | 18175754
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of DOCK4 mRNA | decreases expression | 19465110
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenobarbital |
8.57 | 6195326 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
8.57 | 15322242 11752688 14514962 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.17 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
4.50 | 20127859 20464547 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
4.50 | 17418594 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.68 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Phenobarbital |
17.79 | 17620307 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
17.79 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
17.79 | 16835633 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.61 | 21441931 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.00 | 11748828 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.15 | 19183758 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
3.96 | 15238619 |
MESH:D001321 |
Autistic Disorder |
marker/mechanism |
|
| 19401682 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
8.95 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
8.95 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.89 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.80 | 15746008 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
4.80 | 14601052 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
3.86 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
2.35 | 17474063 20146248 |
MESH:D001943 |
Breast Neoplasms |
|
Calcitriol |
2.35 | 11237771 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
2.35 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
2.35 | 15692762 15634643 18382427 18628466 15994142 16595493 16322301 18695136 15567936 16935488 18234424 15939500 17426702 15136595 16826403 16264153 15668708 19526202 15993339 16096432 16115903 17983394 11325840 17369602 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.35 | 20435547 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
4.91 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.84 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
4.72 | 21507988 12619106 12907637 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
4.72 | 16023760 18059187 16234567 17876044 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Phenobarbital |
4.72 | 1701930 20935162 17173139 20007298 6705139 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
3.18 | 1485588 16201981 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
7.68 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Calcitriol |
7.68 | 11237771 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
7.68 | 6189445 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.39 | 18850075 16120746 18670907 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.56 | 16269455 15476868 16651473 17007740 18627295 17382496 17131338 16242529 17329180 17519947 16364871 16455267 17351982 17928571 15811867 16612575 16731534 17974986 15792986 17308081 16278810 17924179 16952015 16109756 15505089 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.96 | 16243910 17334414 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.76 | 20889678 |
MESH:D002493 |
Central Nervous System Diseases |
|
Phenobarbital |
4.32 | 4080065 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.21 | 16835633 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
2.86 | 19176532 |
MESH:D019457 |
Chromosome Breakage |
|
Sodium Selenite |
4.82 | 15894690 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.12 | 8697196 16354765 12621046 15668235 15340226 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
2.14 | 18802399 18259882 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.11 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 15322242 20055451 10048152 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.45 | 18249437 |
MESH:D003920 |
Diabetes Mellitus |
|
Sodium Selenite |
3.82 | 16285004 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.68 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
6.36 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Sodium Selenite |
6.36 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
6.36 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
8.24 | 18602426 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
8.24 | 11462148 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
3.49 | 18367378 |
MESH:D004421 |
Dystonia |
|
Phenobarbital |
4.06 | 1851702 |
MESH:D004487 |
Edema |
|
pirinixic acid |
6.72 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
6.72 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.00 | 15322242 18230668 16714409 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Calcitriol |
4.00 | 15138306 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
3.48 | 17359293 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.07 | 9294722 10568697 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
5.25 | 18037988 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Phenobarbital |
4.18 | 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Phenobarbital |
3.97 | 3922381 11558140 |
MESH:D004827 |
Epilepsy |
|
Phenobarbital |
2.91 | 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Phenobarbital |
3.59 | 6401628 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenobarbital |
4.32 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenobarbital |
4.10 | 3659116 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
4.39 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
4.39 | 16530937 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.05 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
7.88 | 19551842 19004024 18296743 17967931 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
7.88 | 20131406 19236843 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.53 | 11858732 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
4.67 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
8.87 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
8.87 | 20067830 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
3.38 | 17150277 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.69 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
3.56 | 15692506 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
6.54 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.54 | 10048152 11294989 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.52 | 16244371 16495754 16144979 16244372 12587719 14766674 17888722 16879835 16330681 18006777 16707910 17875725 18674790 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
7.16 | 17481944 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
7.16 | 20558911 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.95 | 15692506 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.39 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Phenobarbital |
14.82 | 16109766 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
14.82 | 18467677 19772884 16221962 19176532 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
14.82 | 12621046 16120746 15340226 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
3.45 | 18501091 17606976 15147373 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.14 | 16354765 15340226 16959395 8697196 18606429 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
3.65 | 21332399 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.23 | 20558911 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
3.67 | 21332399 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.92 | 18850075 18670907 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
5.00 | 20412841 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
5.00 | 12878042 12200463 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
12.54 | 18457598 11836018 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
12.54 | 16306350 |
MESH:D007333 |
Insulin Resistance |
|
Sodium Selenite |
12.54 | 14714311 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.39 | 16580747 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
3.08 | 16775033 15369732 15699352 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
4.21 | 16707910 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
5.25 | 16085563 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
6.76 | 18296743 |
MESH:D008103 |
Liver Cirrhosis |
|
Phenobarbital |
6.76 | 21047994 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
3.47 | 16439617 16595196 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
3.47 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.47 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Phenobarbital |
2.18 | 19363144 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
14.44 | 9163691 15890375 2125692 18177683 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
14.44 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
Phenobarbital |
14.44 | 8742319 21047994 19812893 15975961 19073162 19482888 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
14.44 | 20007298 15890375 16377806 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
14.44 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
19.03 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
19.03 | 17085340 16842330 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
kojic acid |
19.03 | 18544905 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Phenobarbital |
19.03 | 1399818 6150874 2563599 17172636 18308698 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
19.03 | 12151625 |
MESH:D055370 |
Lung Injury |
|
Asbestos, Crocidolite |
4.09 | 17365036 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
4.89 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
4.89 | 20869020 6695378 18816296 18520028 20064080 17053015 20464547 20135361 18569708 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
4.89 | 6189445 17418594 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
4.89 | 19555203 11884234 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
3.50 | 16098063 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Sodium Selenite |
4.12 | 14737004 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
3.83 | 17654614 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.64 | 15621674 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
3.06 | 15458769 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
2.29 | 16827129 |
MESH:D008654 |
Mesothelioma |
|
Asbestos, Crocidolite |
6.50 | 16166281 16966607 18303189 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
6.50 | 17638057 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.55 | 15792986 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.23 | 16381670 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.87 | 17415656 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.58 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
5.78 | 15857846 19429709 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
5.78 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.06 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
2.99 | 16411023 |
MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenobarbital |
4.56 | 17484760 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
2.97 | 18259882 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
4.90 | 11141357 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
4.90 | 17405874 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.84 | 16899518 16636307 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
4.05 | 15640375 16889571 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.28 | 14600291 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
3.29 | 15555623 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
4.47 | 19632207 16723640 18674790 18457598 20518802 17217161 11836018 21332399 20132043 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
4.47 | 20558911 |
MESH:D010018 |
Osteomalacia |
|
Phenobarbital |
4.45 | 17016548 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
4.16 | 15930896 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Phenobarbital |
2.51 | 16965848 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.35 | 12520081 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
5.25 | 17983394 |
MESH:D010995 |
Pleural Diseases |
|
Asbestos, Crocidolite |
4.96 | 10923243 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
5.25 | 17638057 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.62 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Phenobarbital |
3.67 | 2563599 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.27 | 11118676 11399792 11222880 11896295 |
MESH:D011470 |
Prostatic Hyperplasia |
|
Calcitriol |
4.86 | 15572423 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.09 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Calcitriol |
2.09 | 16289102 18247401 16644109 15754350 12479363 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
2.09 | 18437689 15749863 16729912 15897917 16868541 16888761 |
MESH:D011471 |
Prostatic Neoplasms |
|
Sodium Selenite |
2.09 | 18760546 |
MESH:D019310 |
Pseudolymphoma |
|
Phenobarbital |
4.59 | 12752131 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Asbestos, Crocidolite |
3.05 | 15814490 17365031 17322281 17975199 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
4.29 | 17922066 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.41 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.90 | 18990726 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
4.04 | 15625365 17203757 17710206 16767912 18313854 15675481 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
4.31 | 14601052 16326096 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.87 | 17846226 |
MESH:D012640 |
Seizures |
|
Phenobarbital |
2.73 | 3137016 16876388 4039156 11442880 |
MESH:D003294 |
Seizures, Febrile |
|
Phenobarbital |
4.90 | 6407741 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
13.77 | 10029692 19755658 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
13.77 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
13.77 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
13.77 | 16192470 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.64 | 15625365 16767912 17203757 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
1.56 | 2093021 20155912 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.00 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
7.46 | 17909728 16010429 |
MESH:D013964 |
Thyroid Neoplasms |
|
Phenobarbital |
7.46 | 1399818 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
5.21 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
5.21 | 17653716 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.69 | 12125929 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
4.29 | 17638931 16364871 17678736 17334414 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.35 | 15886252 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
3.79 | 16723640 |